We hypothesised that the systemic consequences are evident in a further group of subjects with COPD due to Alpha-1 Antitrypsin Deficiency (A1ATD), yet are currently under-recognised. The gene discussed is PSMA6; the disease is chronic obstructive pulmonary disease.